Trials / Completed
CompletedNCT00596050
Ketamine Versus Etomidate for Procedural Sedation for Pediatric Orthopedic Reductions
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Drexel University College of Medicine · Academic / Other
- Sex
- All
- Age
- 5 Years – 18 Years
- Healthy volunteers
- Accepted
Summary
There are multiple retrospective studies detailing the use of etomidate in pediatric procedural sedation but few to no prospective clinical trials. None have compared etomidate to ketamine, currently the most commonly used sedative in the emergency department for pediatric procedural sedation. The investigators propose a randomized, controlled trial comparing etomidate versus ketamine for procedural sedation for fracture reduction for children presenting with extremity fracture requiring sedation for reduction. The investigators hypothesize that etomidate in combination with fentanyl will have similar reduction of distress and procedural recall as ketamine in combination with midazolam.
Detailed description
There are multiple retrospective studies detailing the use of etomidate in pediatric procedural sedation but few to no prospective clinical trials. None have compared etomidate to ketamine, currently the most commonly used sedative in the emergency department for pediatric procedural sedation. The investigators propose a randomized, controlled trial comparing etomidate versus ketamine for procedural sedation for fracture reduction for children presenting with extremity fracture requiring sedation for reduction. The investigators hypothesize that etomidate in combination with fentanyl will have similar reduction of distress and procedural recall as ketamine in combination with midazolam.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ketamine and midazolam | ketamine 1 mg/kg/dose, midazolam 0.05 mg/kg/dose max 2 mg |
| DRUG | etomidate, fentanyl, and lidocaine | etomidate 0.2 mg/kg/dose, fentanyl 1 microgram/kg/dose, lidocaine 0.5 mg/kg/dose |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-01-16
- Last updated
- 2017-05-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00596050. Inclusion in this directory is not an endorsement.